CDK5 and Alzheimer disease: We suppose that in AD the aberrant coupling of upstream regulator CDK5 with p25 and further currently unknown mechanisms contribute to decreased activity and expression of LMTK2 which leads to overactivation of GSK3β and ultimately to the formation of hyperphosphorylated tau and NFTs.